OverviewSuggest Edit

    Neurotron Biotechnology is a medical device company that designs, develops, and markets neurostimulation systems. It offers the Venus Cochlear Implant System, a solution for adults and children suffering from severe to profound hearing loss. The company is also engaged in the development of auditory brainstem implants, artificial retina systems, and systems to treat paralysis due to stroke.

    Latest Updates

    Cybersecurity ratingAMore

    Neurotron Financials and Metrics

    Summary Metrics

    Founding Date


    Neurotron Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    Neurotron Online and Social Media Presence

    Embed Graph

    Neurotron Frequently Asked Questions

    • When was Neurotron founded?

      Neurotron was founded in 2006.

    • Who are Neurotron competitors?

      Competitors of Neurotron include Synapse Biomedical, OriGen Biomedical and Silvergreen.